Generic products

For dmgs approved originally between 1938 and 1962, the FDA has utilized the Abbreviated New Dmg AppHcation (ANDA) for review of generic products that are pharmaceutical equivalents of the initially approved products. In this way, costiy dupHcation of animal and human experimentation is avoided. The new manufacturer has to show only that its manufacturing methodology, specifications, quaUty control, and labeling are acceptable. In some cases, the FDA does require proof of bioequivalence. 

Now, for this second edition, an attempt was made to list the top prescription drugs in the U.S. as of 1985-some ten years later than the earlier tabulation. This new listing was done by the author based on his interpretation of the sales list by trade name in the magazine/1/ne/-/car) Druggist for February 1986 it gives approximate rank by generic product as of the date of manuscript preparation in 1986. See Table 2. 

Oxidant Formation. The role of HO. in controlling the time-scale and severity of tropospheric oxidant pollution may be seen from the parameterization of O Brien and co-workers (75,76). The simplest possible mechanism for oxidant (Le. ozone, PAN, H2O2, etc.) formation consists simply of the reaction of an individual NNlHCj with HO. to convert the NMHCj to a generic product(s) PRODj, followed by removal of the product by HO. (PROD photolysis may be important, but is ignored here)... 

In Venezuela, there is no official fast-track system. However, brief-mode registration is available for generic products for which a bioavailabilily study has been undertaken. Similarly, Malaysia has an abridged procedure for registration of products classified as non-scheduled poisons. This type of simplified procedure does not, in essence, differ from the use of less stringent registration requirements for certain categories of products as seen, for example, for herbal medicines in Australia and the Netherlands. 

Before a marketing approval document, such as an NDA or ANDA, is finally approved by FDA, an inspection by investigators of the local district office will be arranged [3]. This inspection can provide an additional level of assurance that a generic product will indeed meet all required quality standards. 

Some commentators on bioequivalency have voiced concerns as to whether it is appropriate for states to second-guess the FDA on matters concerning bioequivalency. Once FDA has carefully evaluated an ANDA and decided that the generic product should be approved and given a rating that allows for substitution, it seems hard to conceive any likely circumstances under which an individual state should be able to opt... 

Third, information on the brand or generic name under which each product is marketed is useful for our study. In the English information we cannot distinguish the various generic products that offer the same active ingredients. The data for all the competitors that offer these products are grouped together. 

Note Weighted average calculated on the basis of the number of packages prescribed. It is not possible to distinguish between generic products marketed by different laboratories. 

Gemfibrozil, fenofibrate, and lovastatin are available as generic products. This table does not include all drugs used for treating dyslipidemia. 

The company that applies for approval of the generic product must present full chemical and pharmaceutical documentation. If the new product does not fall within the definition of a generic medicinal product compared to the reference product the results of the appropriate pre-clinical tests or clinical trials should be provided (EU 2001 specific Article 10 (3)). It should be noted that the pharmaceutical and chemical quality is strictly regulated and includes all medications. 

Omeprazole XPharma is a generic product which is bioequivalent to the original products, MUPS included. 

---